The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.

JJ Cornelissen, A Gratwohl, RF Schlenk, J Sierra, M Bornhäuser, Råcil Z Juliusson G, JM Rowe, N Russell, M Mohty, B Löwenberg, G Socié, Ossenkoppele GJ. Niederwieser D

Research output: Contribution to journalArticleResearch

298 Citations (Scopus)
Original languageEnglish
Pages (from-to)579-590
JournalNat Rev Clin Oncol
Issue number10579
Publication statusPublished - 1 Oct 2012

Cite this